Giapreza

Active Ingredient(s): Angiotensin II
FDA Approved: * December 21, 2017
Pharm Company: * LA JOLLA PHARM CO
Category: Blood Pressure

2WXW, 2X0B, 4APH,%%s1N9U, 1N9V,%%s1N9V, 1N9U, 3CK0, 4AA1, 4APH, 5E2QIdentifiersAliasesAGT, ANHU, SERPINA8, hFLT1, angiotensinogenExternal IDsMGI: 87963 HomoloGene: 14 GeneCards: AGT Gene location (Human)Chr.Chromosome 1 (human)[1]Band1q42.2Start230,690,776 bp[1]End230,745,576 bp[1]Gene location (Mouse)Chr.Chromosome 8 (mouse)[2]Band8 E2|8 72.81 cMStart125,283,273 bp[2]End125,296,445 bp[2]R... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Giapreza 2.5 mg/ml Intravenous Injection
NDC: 68547-501
Labeler:
La Jolla Pharmaceutical Company